Log in to save to my catalogue

COVID-19 Testing and Diagnostics: A Review of Commercialized Technologies for Cost, Convenience and...

COVID-19 Testing and Diagnostics: A Review of Commercialized Technologies for Cost, Convenience and...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a016025ab1604ed09e25da549e07ee24

COVID-19 Testing and Diagnostics: A Review of Commercialized Technologies for Cost, Convenience and Quality of Tests

About this item

Full title

COVID-19 Testing and Diagnostics: A Review of Commercialized Technologies for Cost, Convenience and Quality of Tests

Publisher

Basel: MDPI AG

Journal title

Sensors (Basel, Switzerland), 2021-10, Vol.21 (19), p.6581

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Population-scale and rapid testing for SARS-CoV-2 continues to be a priority for several parts of the world. We revisit the in vitro technology platforms for COVID-19 testing and diagnostics—molecular tests and rapid antigen tests, serology or antibody tests, and tests for the management of COVID-19 patients. Within each category of tests, we revie...

Alternative Titles

Full title

COVID-19 Testing and Diagnostics: A Review of Commercialized Technologies for Cost, Convenience and Quality of Tests

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a016025ab1604ed09e25da549e07ee24

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a016025ab1604ed09e25da549e07ee24

Other Identifiers

ISSN

1424-8220

E-ISSN

1424-8220

DOI

10.3390/s21196581

How to access this item